Exploring the Coronavirus Pandemic: Expert Insights on Tackling the Outbreak

﻿The first few months of 2020 have seen the spread of the novel coronavirus (SARS-CoV-2) across the globe and with it, an almost constant stream of news coverage, research and opinions. To help cut through the noise, we wanted to hear from experts to find out what we already know about the outbreak and how it is being tackled.

Disease Modeling Phylogenetics

In this interview, Dr Emma Hodcroft, a Molecular Epidemiologist from the University of Basel, explains how disease modeling works and the impact that limitations have had on our reactions to the COVID-19 outbreak.

Viruses and Antiviral Therapies

Prof. Ben tenOever from Icahn School of Medicine at Mount Sinai discusses the coronavirus pandemic and the possibility of using antiviral therapies to tackle the spread of the virus.

Making Sense of the Pandemic

We speak with Dr Joe Hanson from “It's Okay to Be Smart” about the reality of COVID-19, making sense of the situation and how to understand the science behind this pandemic.

Scientists on Standby – Working Together to Beat Coronavirus

Dr Paul Avery talks to The Science Explorer about Scientists on Standby – a volunteer organization whose goal is to create a real-time network of overflow scientists, labs and other partners that will work together to help meet the testing needs of hospitals and other healthcare providers.

Expanding COVID-19 Testing in Shipping Container Labs

In this interview, Marcus Walker and Matthew Donora from Open Cell, a collaborative lab facility based in London's Shepherd's Bush, discuss how they plan to help increase the UK's COVID-19 testing capacity by tens of thousands of tests per day.

Developing New Diagnostic Test for COVID-19

Dr Ben Orsburn describes a new LCMS assay for testing COVID-19 and the need for expanding testing labs.

Advertisement

RELATED ARTICLES

A global coalition involving over 500 scientists, known as the COVID-19 MS Coalition, was announced earlier this week. The coalition aims to share mass spectrometry data on COVID-19 for the purpose of novel biomarker discovery and understanding the infection more deeply at a molecular level. Technology Networks spoke with Perdita Barran to find out more.

In a recent interview with Technology Networks, Dr Stephen Wright, Independent Consultant in medicines development, talks us through the various stages of clinical drug development. He explains what is meant by an IND application, discusses how clinical trials are designed and how the data generated in these trials is processed.